Status:
COMPLETED
Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells
Lead Sponsor:
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Conditions:
Anemia
Eligibility:
All Genders
Brief Summary
The MATER study is an observational cohort study on first ever transfusion recipients in six hospitals in the Netherlands, with information collected on both donor and patient characteristics. We aim ...
Detailed Description
Background In 2011, a link between donor sex and death of transfusion recipients was observed in red blood cell transfusions (Middelburg et al., Vox Sanquinis, 2011). This was further investigated by ...
Eligibility Criteria
Inclusion
- have received a first transfusion between 20-03-2004 and 31-12-2018 in one of the hospitals participating in the R-FACT study OR
- have donated blood for a blood product which was used in one of the hospitals participating in the R-FACT study between 20-03-2004 and 31-12-2018
Exclusion
- N.A.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
101000 Patients enrolled
Trial Details
Trial ID
NCT06176105
Start Date
October 1 2019
End Date
October 1 2020
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanquin blood bank
Amsterdam, Netherlands, 1066 CX